Skip to main content
IMCC
NASDAQ Life Sciences

IM Cannabis Receives Nasdaq Delisting Warning for Sub-$1.00 Bid Price

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.361
Mkt Cap
$2.246M
52W Low
$0.295
52W High
$7.12
52W Position info
22% above low
Off High info
95% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

IMCC sits 22% above its 52-week low of $0.295 on light trading volume (0.3× avg).

Summary

IM Cannabis Corp. received a Nasdaq notification for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day period to regain compliance and avoid potential delisting.


Key Events · Corporate Governance and Compliance · IMCC

  • Nasdaq Minimum Bid Price Notification

    IM Cannabis Corp. received a notice from Nasdaq for non-compliance with the $1.00 minimum bid price rule.

  • 180-Day Compliance Period

    The company has until October 6, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days.

  • Potential Delisting Risk

    Failure to meet the requirement within the grace period(s) could result in the delisting of the company's common shares from the Nasdaq Capital Market.

  • Management Response

    The company intends to monitor its share price and explore options to cure the deficiency, emphasizing that continued Nasdaq listing is a priority.


Analysis · IMCC · Life Sciences

IM Cannabis Corp. has received a formal notification from Nasdaq regarding its non-compliance with the minimum bid price requirement, as its shares have traded below $1.00. This is a critical development for the company, as continued listing on Nasdaq is vital for liquidity and investor access. While the company has 180 days to regain compliance, the significant gap between the current share price ($0.3605) and the $1.00 threshold presents a substantial challenge. Failure to resolve this could lead to delisting, severely impacting shareholder value and the company's ability to raise capital. Investors should monitor the company's plans to address this deficiency, which may include a reverse stock split.

At the time of this filing, IMCC was trading at $0.36 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.2M. The 52-week trading range was $0.30 to $7.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IMCC - Latest Insights

IMCC
Jul 01, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.1541
Real-time Price: $0.1057 info
Change: -$0.0484 (-31%) info
Market Cap: $980.999K info
IMCC
Jun 18, 2026, 7:32 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.1989
Real-time Price: $0.1057 info
Change: -$0.0932 (-47%) info
Market Cap: $980.999K info
IMCC
Jun 09, 2026, 4:01 PM EDT
Filing Type: F-3
Importance Score:
9
Price at Filing: $0.253
Real-time Price: $0.1057 info
Change: -$0.1473 (-58%) info
Market Cap: $980.999K info
IMCC
Jun 03, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.3091
Real-time Price: $0.1057 info
Change: -$0.2034 (-66%) info
Market Cap: $980.999K info
IMCC
May 13, 2026, 4:55 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.250
Real-time Price: $0.1057 info
Change: -$0.1443 (-58%) info
Market Cap: $980.999K info